

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.01346911 |
| 2 | response to parathyroid hormone (GO:0071107) | 9.00431822 |
| 3 | polyol transport (GO:0015791) | 8.84428238 |
| 4 | * excretion (GO:0007588) | 8.53091792 |
| 5 | urate metabolic process (GO:0046415) | 8.39845645 |
| 6 | response to mercury ion (GO:0046689) | 8.37465262 |
| 7 | drug transmembrane transport (GO:0006855) | 8.01165223 |
| 8 | lysine metabolic process (GO:0006553) | 7.47894675 |
| 9 | lysine catabolic process (GO:0006554) | 7.47894675 |
| 10 | metanephric nephron tubule development (GO:0072234) | 7.15554122 |
| 11 | metanephric tubule development (GO:0072170) | 7.15554122 |
| 12 | organic cation transport (GO:0015695) | 6.84804047 |
| 13 | drug transport (GO:0015893) | 6.72283654 |
| 14 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 6.65770507 |
| 15 | phosphate ion transport (GO:0006817) | 6.60422537 |
| 16 | metanephric nephron epithelium development (GO:0072243) | 6.57599487 |
| 17 | response to lead ion (GO:0010288) | 6.53519882 |
| 18 | * renal absorption (GO:0070293) | 6.46095921 |
| 19 | response to thyroid hormone (GO:0097066) | 6.39797665 |
| 20 | positive regulation of catenin import into nucleus (GO:0035413) | 6.30140057 |
| 21 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 6.29830799 |
| 22 | metanephric epithelium development (GO:0072207) | 6.15658518 |
| 23 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 6.10555370 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 6.05335702 |
| 25 | negative regulation of sterol transport (GO:0032372) | 6.05335702 |
| 26 | quaternary ammonium group transport (GO:0015697) | 5.77513327 |
| 27 | response to magnesium ion (GO:0032026) | 5.69854612 |
| 28 | phosphate ion transmembrane transport (GO:0035435) | 5.53062735 |
| 29 | ethanol oxidation (GO:0006069) | 5.35630601 |
| 30 | one-carbon compound transport (GO:0019755) | 5.31004570 |
| 31 | nephron tubule development (GO:0072080) | 5.21460472 |
| 32 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.18236731 |
| 33 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 5.17135124 |
| 34 | negative regulation of metanephros development (GO:0072217) | 5.15612064 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 5.14134856 |
| 36 | valine metabolic process (GO:0006573) | 5.13037480 |
| 37 | aspartate family amino acid catabolic process (GO:0009068) | 5.11542104 |
| 38 | hyperosmotic response (GO:0006972) | 5.09007919 |
| 39 | glyoxylate metabolic process (GO:0046487) | 5.06561845 |
| 40 | sodium-independent organic anion transport (GO:0043252) | 5.04625014 |
| 41 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.04609809 |
| 42 | collecting duct development (GO:0072044) | 5.02445299 |
| 43 | nephron tubule formation (GO:0072079) | 5.00966099 |
| 44 | cysteine metabolic process (GO:0006534) | 4.94220229 |
| 45 | inositol metabolic process (GO:0006020) | 4.88467453 |
| 46 | branched-chain amino acid metabolic process (GO:0009081) | 4.84417186 |
| 47 | drug catabolic process (GO:0042737) | 4.74455898 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 4.74421726 |
| 49 | actin filament depolymerization (GO:0030042) | 4.70822333 |
| 50 | modified amino acid transport (GO:0072337) | 4.70542629 |
| 51 | cellular response to ammonium ion (GO:0071242) | 4.70413019 |
| 52 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.68338221 |
| 53 | renal tubule development (GO:0061326) | 4.61833848 |
| 54 | response to growth hormone (GO:0060416) | 4.53739041 |
| 55 | exogenous drug catabolic process (GO:0042738) | 4.48087885 |
| 56 | response to vitamin A (GO:0033189) | 4.47532284 |
| 57 | vitamin D metabolic process (GO:0042359) | 4.46012641 |
| 58 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.41653404 |
| 59 | trivalent inorganic anion homeostasis (GO:0072506) | 4.36967994 |
| 60 | phosphate ion homeostasis (GO:0055062) | 4.36967994 |
| 61 | branched-chain amino acid catabolic process (GO:0009083) | 4.36340212 |
| 62 | bone remodeling (GO:0046849) | 4.31174325 |
| 63 | toxin transport (GO:1901998) | 4.31132101 |
| 64 | 2-oxoglutarate metabolic process (GO:0006103) | 4.28875159 |
| 65 | nephron epithelium development (GO:0072009) | 4.27584547 |
| 66 | homocysteine metabolic process (GO:0050667) | 4.24188149 |
| 67 | regulation of protein localization to cell surface (GO:2000008) | 4.22952467 |
| 68 | glycoside metabolic process (GO:0016137) | 4.19396528 |
| 69 | carnitine transport (GO:0015879) | 4.11125337 |
| 70 | amino-acid betaine transport (GO:0015838) | 4.11125337 |
| 71 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 4.11032420 |
| 72 | glomerular visceral epithelial cell development (GO:0072015) | 4.08841457 |
| 73 | cell volume homeostasis (GO:0006884) | 4.08058623 |
| 74 | regulation of fever generation (GO:0031620) | 4.07566891 |
| 75 | indole-containing compound catabolic process (GO:0042436) | 4.04877335 |
| 76 | indolalkylamine catabolic process (GO:0046218) | 4.04877335 |
| 77 | tryptophan catabolic process (GO:0006569) | 4.04877335 |
| 78 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.02873305 |
| 79 | fatty acid oxidation (GO:0019395) | 4.00771143 |
| 80 | mammary gland alveolus development (GO:0060749) | 4.00198162 |
| 81 | positive regulation of heat generation (GO:0031652) | 3.98601153 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 3.97114412 |
| 83 | amino-acid betaine metabolic process (GO:0006577) | 3.96924065 |
| 84 | pattern specification involved in kidney development (GO:0061004) | 3.94130131 |
| 85 | regulation of cholesterol efflux (GO:0010874) | 3.94008698 |
| 86 | lipid oxidation (GO:0034440) | 3.93454790 |
| 87 | glutathione biosynthetic process (GO:0006750) | 3.92464654 |
| 88 | response to salt stress (GO:0009651) | 3.92340185 |
| 89 | aromatic amino acid family catabolic process (GO:0009074) | 3.91954702 |
| 90 | ERK1 and ERK2 cascade (GO:0070371) | 3.91583159 |
| 91 | carnitine metabolic process (GO:0009437) | 3.89996581 |
| 92 | fatty acid beta-oxidation (GO:0006635) | 3.85461843 |
| 93 | tryptophan metabolic process (GO:0006568) | 3.77167671 |
| 94 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.74480980 |
| 95 | L-phenylalanine metabolic process (GO:0006558) | 3.74480980 |
| 96 | vitamin transmembrane transport (GO:0035461) | 3.73219661 |
| 97 | response to water (GO:0009415) | 3.71854397 |
| 98 | nephron epithelium morphogenesis (GO:0072088) | 3.71447987 |
| 99 | nephron tubule morphogenesis (GO:0072078) | 3.71447987 |
| 100 | water transport (GO:0006833) | 3.68779047 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68403329 |
| 102 | protein depolymerization (GO:0051261) | 3.67437364 |
| 103 | beta-amyloid metabolic process (GO:0050435) | 3.66855209 |
| 104 | L-phenylalanine catabolic process (GO:0006559) | 3.64391084 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.64391084 |
| 106 | fructose metabolic process (GO:0006000) | 3.63197674 |
| 107 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.62397684 |
| 108 | transepithelial transport (GO:0070633) | 3.62338861 |
| 109 | vitamin transport (GO:0051180) | 3.61064867 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 3.59355800 |
| 111 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.58599497 |
| 112 | glomerular epithelial cell development (GO:0072310) | 3.57604662 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 3.51500894 |
| 114 | ethanol metabolic process (GO:0006067) | 3.50772281 |
| 115 | peptide catabolic process (GO:0043171) | 3.49691415 |
| 116 | sulfur compound transport (GO:0072348) | 3.45125656 |
| 117 | response to copper ion (GO:0046688) | 3.44585233 |
| 118 | NADH metabolic process (GO:0006734) | 3.42450865 |
| 119 | ketone body metabolic process (GO:1902224) | 3.38703838 |
| 120 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.38309419 |
| 121 | tricarboxylic acid cycle (GO:0006099) | 3.37727950 |
| 122 | S-adenosylmethionine metabolic process (GO:0046500) | 3.37726515 |
| 123 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.37545800 |
| 124 | kynurenine metabolic process (GO:0070189) | 3.37482255 |
| 125 | surfactant homeostasis (GO:0043129) | 3.35449504 |
| 126 | serine family amino acid catabolic process (GO:0009071) | 3.34201978 |
| 127 | primary alcohol catabolic process (GO:0034310) | 3.32445647 |
| 128 | regulation of anion transport (GO:0044070) | 3.32353061 |
| 129 | sulfur amino acid catabolic process (GO:0000098) | 3.30337734 |
| 130 | proline metabolic process (GO:0006560) | 3.28226245 |
| 131 | L-methionine salvage (GO:0071267) | 3.27150802 |
| 132 | L-methionine biosynthetic process (GO:0071265) | 3.27150802 |
| 133 | amino acid salvage (GO:0043102) | 3.27150802 |
| 134 | fluid transport (GO:0042044) | 3.25439603 |
| 135 | cell differentiation involved in metanephros development (GO:0072202) | 3.25074146 |
| 136 | indole-containing compound metabolic process (GO:0042430) | 3.24172368 |
| 137 | peptide biosynthetic process (GO:0043043) | 3.23129790 |
| 138 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.20243483 |
| 139 | renal tubule morphogenesis (GO:0061333) | 3.18456837 |
| 140 | glutamate metabolic process (GO:0006536) | 3.17249298 |
| 141 | positive regulation of digestive system process (GO:0060456) | 3.16940521 |
| 142 | serine family amino acid metabolic process (GO:0009069) | 3.16619632 |
| 143 | * sodium ion transport (GO:0006814) | 3.16461004 |
| 144 | L-ascorbic acid metabolic process (GO:0019852) | 3.16244955 |
| 145 | fatty acid catabolic process (GO:0009062) | 3.15075990 |
| 146 | regulation of heat generation (GO:0031650) | 3.14441858 |
| 147 | cellular amino acid catabolic process (GO:0009063) | 3.13420365 |
| 148 | response to phenylpropanoid (GO:0080184) | 3.13074596 |
| 149 | regulation of calcium ion import (GO:0090279) | 3.10716897 |
| 150 | response to lithium ion (GO:0010226) | 3.10146180 |
| 151 | glutathione derivative metabolic process (GO:1901685) | 3.10018520 |
| 152 | negative regulation of lipid transport (GO:0032369) | 3.07870952 |
| 153 | inorganic anion transport (GO:0015698) | 3.07694560 |
| 154 | urogenital system development (GO:0001655) | 3.06720740 |
| 155 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.04975903 |
| 156 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.04225247 |
| 157 | chloride transmembrane transport (GO:1902476) | 3.01381380 |
| 158 | * renal system process (GO:0003014) | 3.00198478 |
| 159 | mesonephros development (GO:0001823) | 2.92419745 |
| 160 | inorganic anion transmembrane transport (GO:0098661) | 2.88783414 |
| 161 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.87692351 |
| 162 | histamine transport (GO:0051608) | 2.86284256 |
| 163 | regulation of catenin import into nucleus (GO:0035412) | 2.82725109 |
| 164 | chloride transport (GO:0006821) | 2.79822730 |
| 165 | regulation of stem cell maintenance (GO:2000036) | 2.79750855 |
| 166 | kidney epithelium development (GO:0072073) | 2.77306307 |
| 167 | negative regulation of kidney development (GO:0090185) | 2.76913364 |
| 168 | flavonoid metabolic process (GO:0009812) | 2.76777563 |
| 169 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.70643827 |
| 170 | positive regulation of metanephros development (GO:0072216) | 2.69088955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.28330549 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.61712356 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.26745425 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.19397861 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.16694933 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.89485120 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.89052838 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.70193472 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.67755212 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.52422086 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.43550186 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.41484749 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23109551 |
| 14 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.20383468 |
| 15 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.20182889 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15098215 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.13442986 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.04639355 |
| 19 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.02496105 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92363268 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91202006 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89032902 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86232544 |
| 24 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.84981686 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.82433778 |
| 26 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.80729816 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79200528 |
| 28 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.77970133 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76930798 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72985304 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.70453739 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61601953 |
| 33 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.57778220 |
| 34 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.57529829 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57470395 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55027223 |
| 37 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50172067 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49306354 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.48253233 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45899445 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.41265040 |
| 42 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40724121 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39873920 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39674481 |
| 45 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.39397672 |
| 46 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.39340874 |
| 47 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.38369264 |
| 48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37989488 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36840453 |
| 50 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.35954638 |
| 51 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32654329 |
| 52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31542785 |
| 53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30056488 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29867837 |
| 55 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.28567090 |
| 56 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.28138765 |
| 57 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.28025023 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27146390 |
| 59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26102925 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25725952 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25489390 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25369960 |
| 63 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25124468 |
| 64 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24845842 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24680576 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22708351 |
| 67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22201830 |
| 68 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20908199 |
| 69 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.19026523 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17453752 |
| 71 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.17398023 |
| 72 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.17305837 |
| 73 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.17198899 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14426330 |
| 75 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13289597 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13180292 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12609332 |
| 78 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12560174 |
| 79 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12396350 |
| 80 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12202117 |
| 81 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12202117 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12123800 |
| 83 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12074542 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11640029 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11410188 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11392814 |
| 87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11392814 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11319290 |
| 89 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10995786 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10119127 |
| 91 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09748166 |
| 92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.08439881 |
| 93 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.07196699 |
| 94 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.06534527 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06381137 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06040772 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05985212 |
| 98 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.05141813 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05139407 |
| 100 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.04991175 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03944171 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03481140 |
| 103 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03479746 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02306259 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01169835 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01084094 |
| 107 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01078453 |
| 108 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00787410 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00216202 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99709831 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99709831 |
| 112 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99016066 |
| 113 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98747352 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97142612 |
| 115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96842232 |
| 116 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96115678 |
| 117 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.95980680 |
| 118 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.95876392 |
| 119 | NFYA_21822215_ChIP-Seq_K562_Human | 0.95742239 |
| 120 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94535815 |
| 121 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94448759 |
| 122 | TBL1_22424771_ChIP-Seq_293T_Human | 0.94388612 |
| 123 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94191823 |
| 124 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93847093 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93780609 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93155946 |
| 127 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92905609 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92878964 |
| 129 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92745967 |
| 130 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92035836 |
| 131 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91992108 |
| 132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91803760 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91180859 |
| 134 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91178413 |
| 135 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91077886 |
| 136 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90563428 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89201685 |
| 138 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88080678 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87691513 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87482835 |
| 141 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87133007 |
| 142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87029077 |
| 143 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86344836 |
| 144 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85952411 |
| 145 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84292529 |
| 146 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83696383 |
| 147 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83301612 |
| 148 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82069637 |
| 149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82021394 |
| 150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81902812 |
| 151 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80328754 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79980382 |
| 153 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79849361 |
| 154 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79387334 |
| 155 | * SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.78966205 |
| 156 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77799283 |
| 157 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.77263150 |
| 158 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.77233299 |
| 159 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75902655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004043_abnormal_pH_regulation | 7.52606017 |
| 2 | MP0003195_calcinosis | 6.72344559 |
| 3 | MP0005360_urolithiasis | 5.66597355 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 4.85124141 |
| 5 | * MP0001756_abnormal_urination | 4.56667939 |
| 6 | MP0005332_abnormal_amino_acid | 4.31249561 |
| 7 | * MP0009643_abnormal_urine_homeostasis | 4.11766384 |
| 8 | * MP0001765_abnormal_ion_homeostasis | 3.77216416 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.43365134 |
| 10 | * MP0002136_abnormal_kidney_physiology | 3.23823222 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 3.12248107 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 3.09667258 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 3.01304863 |
| 14 | MP0003878_abnormal_ear_physiology | 3.01304863 |
| 15 | * MP0005636_abnormal_mineral_homeostasis | 3.01191369 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.53165416 |
| 17 | MP0004885_abnormal_endolymph | 2.28365460 |
| 18 | MP0000538_abnormal_urinary_bladder | 2.17478561 |
| 19 | MP0003252_abnormal_bile_duct | 2.12681248 |
| 20 | MP0001958_emphysema | 2.02130210 |
| 21 | MP0005365_abnormal_bile_salt | 1.76433267 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 1.60628631 |
| 23 | MP0003186_abnormal_redox_activity | 1.49427377 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.47797161 |
| 25 | MP0002168_other_aberrant_phenotype | 1.47765896 |
| 26 | MP0000230_abnormal_systemic_arterial | 1.44144345 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34301817 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.33373304 |
| 29 | MP0005451_abnormal_body_composition | 1.19076565 |
| 30 | MP0002928_abnormal_bile_duct | 1.17861371 |
| 31 | * MP0002135_abnormal_kidney_morphology | 1.17574553 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.13434681 |
| 33 | MP0003045_fibrosis | 1.12780294 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.12592278 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.09762862 |
| 36 | MP0003283_abnormal_digestive_organ | 1.07897187 |
| 37 | MP0004742_abnormal_vestibular_system | 1.06578655 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.05831684 |
| 39 | MP0000534_abnormal_ureter_morphology | 0.99828616 |
| 40 | MP0005535_abnormal_body_temperature | 0.99073531 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 0.98402107 |
| 42 | MP0000747_muscle_weakness | 0.97572345 |
| 43 | MP0005670_abnormal_white_adipose | 0.90969866 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.87428214 |
| 45 | MP0001270_distended_abdomen | 0.83624041 |
| 46 | MP0001764_abnormal_homeostasis | 0.83230317 |
| 47 | MP0005165_increased_susceptibility_to | 0.80528269 |
| 48 | MP0009672_abnormal_birth_weight | 0.78590872 |
| 49 | MP0003959_abnormal_lean_body | 0.77803326 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 0.77744861 |
| 51 | MP0005666_abnormal_adipose_tissue | 0.76783566 |
| 52 | MP0005395_other_phenotype | 0.76719624 |
| 53 | MP0004147_increased_porphyrin_level | 0.76380248 |
| 54 | MP0003879_abnormal_hair_cell | 0.73465712 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 0.73407790 |
| 56 | MP0002896_abnormal_bone_mineralization | 0.73330683 |
| 57 | MP0003329_amyloid_beta_deposits | 0.67916817 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 0.67409789 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 0.66559042 |
| 60 | MP0000678_abnormal_parathyroid_gland | 0.64876564 |
| 61 | * MP0009642_abnormal_blood_homeostasis | 0.64634116 |
| 62 | MP0001485_abnormal_pinna_reflex | 0.64258309 |
| 63 | MP0003183_abnormal_peptide_metabolism | 0.62591799 |
| 64 | MP0003638_abnormal_response/metabolism_ | 0.61954385 |
| 65 | MP0009764_decreased_sensitivity_to | 0.60773457 |
| 66 | MP0005375_adipose_tissue_phenotype | 0.59280110 |
| 67 | MP0003646_muscle_fatigue | 0.58646013 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 0.58104155 |
| 69 | MP0010368_abnormal_lymphatic_system | 0.57334521 |
| 70 | MP0002971_abnormal_brown_adipose | 0.57058382 |
| 71 | MP0004484_altered_response_of | 0.56967252 |
| 72 | MP0004272_abnormal_basement_membrane | 0.56625316 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.56169974 |
| 74 | MP0008004_abnormal_stomach_pH | 0.55965942 |
| 75 | MP0005408_hypopigmentation | 0.54398854 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.54284999 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.54188649 |
| 78 | MP0000371_diluted_coat_color | 0.53088436 |
| 79 | MP0001177_atelectasis | 0.52533093 |
| 80 | MP0002098_abnormal_vibrissa_morphology | 0.51586091 |
| 81 | MP0002796_impaired_skin_barrier | 0.50723741 |
| 82 | MP0010329_abnormal_lipoprotein_level | 0.50397446 |
| 83 | MP0003724_increased_susceptibility_to | 0.49919180 |
| 84 | MP0001666_abnormal_nutrient_absorption | 0.49620548 |
| 85 | MP0004858_abnormal_nervous_system | 0.49479337 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.49262565 |
| 87 | * MP0002069_abnormal_eating/drinking_beha | 0.48629025 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.47196140 |
| 89 | MP0008872_abnormal_physiological_respon | 0.46731345 |
| 90 | MP0003303_peritoneal_inflammation | 0.44620181 |
| 91 | MP0003943_abnormal_hepatobiliary_system | 0.44443511 |
| 92 | MP0008874_decreased_physiological_sensi | 0.44432661 |
| 93 | MP0006054_spinal_hemorrhage | 0.43507809 |
| 94 | MP0003953_abnormal_hormone_level | 0.42773568 |
| 95 | MP0001664_abnormal_digestion | 0.41668671 |
| 96 | MP0000604_amyloidosis | 0.40291504 |
| 97 | MP0003795_abnormal_bone_structure | 0.39098340 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.38977391 |
| 99 | MP0001663_abnormal_digestive_system | 0.38899037 |
| 100 | MP0003011_delayed_dark_adaptation | 0.38569197 |
| 101 | MP0003315_abnormal_perineum_morphology | 0.38466618 |
| 102 | MP0000026_abnormal_inner_ear | 0.36802069 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.36765649 |
| 104 | MP0001731_abnormal_postnatal_growth | 0.36534255 |
| 105 | MP0000609_abnormal_liver_physiology | 0.36482319 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.35229531 |
| 107 | MP0005501_abnormal_skin_physiology | 0.34866268 |
| 108 | MP0003690_abnormal_glial_cell | 0.34429919 |
| 109 | MP0003938_abnormal_ear_development | 0.34304945 |
| 110 | MP0003075_altered_response_to | 0.33216451 |
| 111 | MP0008469_abnormal_protein_level | 0.32798876 |
| 112 | MP0005025_abnormal_response_to | 0.32744639 |
| 113 | MP0005388_respiratory_system_phenotype | 0.32067265 |
| 114 | MP0002133_abnormal_respiratory_system | 0.32067265 |
| 115 | MP0001784_abnormal_fluid_regulation | 0.31281680 |
| 116 | MP0001661_extended_life_span | 0.31216977 |
| 117 | MP0009703_decreased_birth_body | 0.28104013 |
| 118 | * MP0001191_abnormal_skin_condition | 0.28066937 |
| 119 | MP0001944_abnormal_pancreas_morphology | 0.25899359 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.24266332 |
| 121 | MP0003941_abnormal_skin_development | 0.22681320 |
| 122 | MP0002115_abnormal_skeleton_extremities | 0.21972967 |
| 123 | MP0004130_abnormal_muscle_cell | 0.21922472 |
| 124 | MP0006082_CNS_inflammation | 0.20276186 |
| 125 | MP0000920_abnormal_myelination | 0.19820318 |
| 126 | MP0004215_abnormal_myocardial_fiber | 0.16981221 |
| 127 | MP0002082_postnatal_lethality | 0.15875486 |
| 128 | MP0010770_preweaning_lethality | 0.15875486 |
| 129 | MP0003633_abnormal_nervous_system | 0.15740196 |
| 130 | MP0005671_abnormal_response_to | 0.14645693 |
| 131 | MP0004233_abnormal_muscle_weight | 0.14355801 |
| 132 | MP0000631_abnormal_neuroendocrine_gland | 0.12858759 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.12679717 |
| 134 | MP0003866_abnormal_defecation | 0.11957773 |
| 135 | MP0003091_abnormal_cell_migration | 0.11774261 |
| 136 | MP0005464_abnormal_platelet_physiology | 0.11198650 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.11195737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Increased circulating renin level (HP:0000848) | 8.63070607 |
| 2 | * Polyuria (HP:0000103) | 8.47290077 |
| 3 | * Abnormality of chloride homeostasis (HP:0011422) | 8.37336442 |
| 4 | * Hypomagnesemia (HP:0002917) | 8.15047780 |
| 5 | * Abnormal urine output (HP:0012590) | 7.82689523 |
| 6 | * Hyperactive renin-angiotensin system (HP:0000841) | 7.72748084 |
| 7 | * Abnormality of renal excretion (HP:0011036) | 7.11232040 |
| 8 | * Abnormality of magnesium homeostasis (HP:0004921) | 6.87318231 |
| 9 | * Hyperaldosteronism (HP:0000859) | 6.75343526 |
| 10 | * Renal salt wasting (HP:0000127) | 6.59143846 |
| 11 | * Polydipsia (HP:0001959) | 6.24575291 |
| 12 | * Abnormal drinking behavior (HP:0030082) | 6.24575291 |
| 13 | Gout (HP:0001997) | 6.06260579 |
| 14 | * Alkalosis (HP:0001948) | 5.90434955 |
| 15 | * Tetany (HP:0001281) | 5.86462768 |
| 16 | * Abnormality of renin-angiotensin system (HP:0000847) | 5.58564837 |
| 17 | * Hypokalemia (HP:0002900) | 4.83629063 |
| 18 | Increased purine levels (HP:0004368) | 4.34449607 |
| 19 | Hyperuricemia (HP:0002149) | 4.34449607 |
| 20 | Abnormality of sodium homeostasis (HP:0010931) | 4.22167353 |
| 21 | * Abnormality of potassium homeostasis (HP:0011042) | 4.00165032 |
| 22 | Proximal tubulopathy (HP:0000114) | 3.82557338 |
| 23 | Hyponatremia (HP:0002902) | 3.77310212 |
| 24 | Hyperglycinuria (HP:0003108) | 3.62011861 |
| 25 | * Hypercalciuria (HP:0002150) | 3.58963694 |
| 26 | Abnormality of purine metabolism (HP:0004352) | 3.58033267 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.20135343 |
| 28 | Renal tubular acidosis (HP:0001947) | 3.19373929 |
| 29 | * Adrenal overactivity (HP:0002717) | 3.05220287 |
| 30 | Ketoacidosis (HP:0001993) | 3.04410431 |
| 31 | Decreased circulating renin level (HP:0003351) | 2.99994531 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.95757587 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 2.95757587 |
| 34 | * Abnormality of fatty-acid metabolism (HP:0004359) | 2.83496463 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.81471452 |
| 36 | Abnormality of urine glucose concentration (HP:0011016) | 2.63158209 |
| 37 | Glycosuria (HP:0003076) | 2.63158209 |
| 38 | * Dehydration (HP:0001944) | 2.61729811 |
| 39 | * Nephrocalcinosis (HP:0000121) | 2.55717914 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 2.51379562 |
| 41 | Ketosis (HP:0001946) | 2.45927597 |
| 42 | Tubulointerstitial fibrosis (HP:0005576) | 2.39010050 |
| 43 | Tubular atrophy (HP:0000092) | 2.31368868 |
| 44 | Hyperphosphaturia (HP:0003109) | 2.29798366 |
| 45 | Abnormal urine phosphate concentration (HP:0012599) | 2.18953096 |
| 46 | Hyperglycinemia (HP:0002154) | 2.17635547 |
| 47 | * Chondrocalcinosis (HP:0000934) | 2.09023062 |
| 48 | Potter facies (HP:0002009) | 2.06168579 |
| 49 | Facial shape deformation (HP:0011334) | 2.06168579 |
| 50 | Nephrolithiasis (HP:0000787) | 2.05770828 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.03557360 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.03557360 |
| 53 | Renal tubular dysfunction (HP:0000124) | 2.01797661 |
| 54 | * Vomiting (HP:0002013) | 2.01449368 |
| 55 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.01289533 |
| 56 | * Metabolic alkalosis (HP:0200114) | 10.1652076 |
| 57 | * Hypokalemic alkalosis (HP:0001949) | 10.1434386 |
| 58 | Neonatal onset (HP:0003623) | 1.99757208 |
| 59 | * Abnormality of Sharpey fibers (HP:0100685) | 1.97824027 |
| 60 | Glomerulosclerosis (HP:0000096) | 1.93123288 |
| 61 | Hyperkalemia (HP:0002153) | 1.91058164 |
| 62 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91019436 |
| 63 | Vascular calcification (HP:0004934) | 1.84343179 |
| 64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.83880237 |
| 65 | Metabolic acidosis (HP:0001942) | 1.82868665 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 1.82868606 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82868606 |
| 68 | Hypophosphatemia (HP:0002148) | 1.82791653 |
| 69 | Delayed epiphyseal ossification (HP:0002663) | 1.81619909 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 1.80941683 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 1.80606425 |
| 72 | Delayed CNS myelination (HP:0002188) | 1.78261886 |
| 73 | Abnormality of renal resorption (HP:0011038) | 1.78001799 |
| 74 | Enlarged kidneys (HP:0000105) | 1.75817118 |
| 75 | Hyperammonemia (HP:0001987) | 1.75663930 |
| 76 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73777179 |
| 77 | Rickets (HP:0002748) | 1.70534465 |
| 78 | Widely patent fontanelles and sutures (HP:0004492) | 1.68812610 |
| 79 | * Hypotension (HP:0002615) | 1.67477575 |
| 80 | * Generalized muscle weakness (HP:0003324) | 1.66177749 |
| 81 | Cardiovascular calcification (HP:0011915) | 1.62887600 |
| 82 | Irritability (HP:0000737) | 1.62596190 |
| 83 | Bicornuate uterus (HP:0000813) | 1.60001960 |
| 84 | Tubulointerstitial abnormality (HP:0001969) | 1.56007153 |
| 85 | Metaphyseal cupping (HP:0003021) | 1.55770810 |
| 86 | Methylmalonic aciduria (HP:0012120) | 1.51722236 |
| 87 | Lethargy (HP:0001254) | 1.51603130 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.48135816 |
| 89 | Abnormality of the renal medulla (HP:0100957) | 1.47455282 |
| 90 | Lymphangioma (HP:0100764) | 1.45583478 |
| 91 | Elevated alkaline phosphatase (HP:0003155) | 1.44634727 |
| 92 | Hypothermia (HP:0002045) | 1.44600611 |
| 93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.41492552 |
| 94 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.40405404 |
| 95 | Confusion (HP:0001289) | 1.39944919 |
| 96 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.38601248 |
| 97 | Metaphyseal dysplasia (HP:0100255) | 1.38018164 |
| 98 | Thin bony cortex (HP:0002753) | 1.36322943 |
| 99 | Tachypnea (HP:0002789) | 1.33722951 |
| 100 | Hypoglycemic coma (HP:0001325) | 1.32492819 |
| 101 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.28844036 |
| 102 | Intellectual disability, moderate (HP:0002342) | 1.28314853 |
| 103 | Abnormal eating behavior (HP:0100738) | 1.27318644 |
| 104 | Nausea (HP:0002018) | 1.26757336 |
| 105 | * Premature birth (HP:0001622) | 1.26104806 |
| 106 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.25424892 |
| 107 | Malnutrition (HP:0004395) | 1.21469066 |
| 108 | Abnormality of serum amino acid levels (HP:0003112) | 1.21404929 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.19413618 |
| 110 | Abnormal tarsal ossification (HP:0008369) | 1.14233458 |
| 111 | Neonatal death (HP:0003811) | 1.12072664 |
| 112 | Enlarged epiphyses (HP:0010580) | 1.09461482 |
| 113 | * Osteopenia (HP:0000938) | 1.07960105 |
| 114 | * Paresthesia (HP:0003401) | 1.06811519 |
| 115 | Persistence of primary teeth (HP:0006335) | 1.05366744 |
| 116 | Hypophosphatemic rickets (HP:0004912) | 1.02738863 |
| 117 | Thyroid-stimulating hormone excess (HP:0002925) | 0.98345786 |
| 118 | Esophageal varix (HP:0002040) | 0.97514357 |
| 119 | Metaphyseal irregularity (HP:0003025) | 0.94983769 |
| 120 | Osteomalacia (HP:0002749) | 0.94757551 |
| 121 | Abnormality of macular pigmentation (HP:0008002) | 0.90122707 |
| 122 | Juvenile onset (HP:0003621) | 0.88097977 |
| 123 | Abnormality of the fingertips (HP:0001211) | 0.87737932 |
| 124 | * Polyhydramnios (HP:0001561) | 0.87213141 |
| 125 | Paralysis (HP:0003470) | 0.86173473 |
| 126 | Hyperphosphatemia (HP:0002905) | 0.82557769 |
| 127 | Amelogenesis imperfecta (HP:0000705) | 0.77894264 |
| 128 | Abnormal foot bone ossification (HP:0010675) | 0.77355643 |
| 129 | Nephropathy (HP:0000112) | 0.75414591 |
| 130 | Choanal stenosis (HP:0000452) | 0.74302244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 7.96148945 |
| 2 | WNK4 | 7.95086987 |
| 3 | STK39 | 3.99260914 |
| 4 | TIE1 | 3.33558561 |
| 5 | WNK3 | 10.2399719 |
| 6 | BCKDK | 1.94857261 |
| 7 | STK38L | 1.84879334 |
| 8 | WNK1 | 1.79708483 |
| 9 | MST4 | 1.38656349 |
| 10 | PDK2 | 1.36016343 |
| 11 | PDK4 | 1.29606888 |
| 12 | PDK3 | 1.29606888 |
| 13 | SIK3 | 1.16784208 |
| 14 | STK38 | 0.92551780 |
| 15 | INSRR | 0.89996160 |
| 16 | NEK1 | 0.85733767 |
| 17 | PINK1 | 0.75490231 |
| 18 | PRKD3 | 0.72167556 |
| 19 | MST1R | 0.70218257 |
| 20 | ERN1 | 0.69728736 |
| 21 | * SGK223 | 0.66301349 |
| 22 | * SGK494 | 0.66301349 |
| 23 | SIK1 | 0.63895012 |
| 24 | TGFBR2 | 0.63793600 |
| 25 | GRK1 | 0.61139382 |
| 26 | LRRK2 | 0.56590355 |
| 27 | SIK2 | 0.52101616 |
| 28 | MAPK15 | 0.51830378 |
| 29 | BMX | 0.51297391 |
| 30 | PRKD2 | 0.51190643 |
| 31 | PRKAA1 | 0.49797103 |
| 32 | CAMKK2 | 0.45771221 |
| 33 | MAP3K7 | 0.44621199 |
| 34 | EPHB2 | 0.42932370 |
| 35 | PIK3CG | 0.41229667 |
| 36 | PRKCI | 0.37824808 |
| 37 | EPHB1 | 0.35196605 |
| 38 | MARK3 | 0.34942746 |
| 39 | MAP3K12 | 0.34613496 |
| 40 | * SGK1 | 0.33578268 |
| 41 | STK10 | 0.32149785 |
| 42 | FGFR4 | 0.31416429 |
| 43 | GSK3A | 0.31255539 |
| 44 | PRKAA2 | 0.30384124 |
| 45 | LATS1 | 0.29728527 |
| 46 | TEC | 0.29326300 |
| 47 | PAK3 | 0.28636568 |
| 48 | SCYL2 | 0.26953982 |
| 49 | PDPK1 | 0.26542020 |
| 50 | PRKCH | 0.24690610 |
| 51 | PRKCZ | 0.24337543 |
| 52 | * SGK2 | 0.23086830 |
| 53 | CAMK1D | 0.22783057 |
| 54 | PAK4 | 0.22662799 |
| 55 | CAMK1G | 0.22586274 |
| 56 | DAPK2 | 0.21968218 |
| 57 | PTK2 | 0.21936478 |
| 58 | PRKCE | 0.21134597 |
| 59 | MAP3K3 | 0.19514510 |
| 60 | FER | 0.18957992 |
| 61 | GRK6 | 0.18149617 |
| 62 | IRAK2 | 0.17269392 |
| 63 | CSNK1A1 | 0.17038581 |
| 64 | * SGK3 | 0.16824951 |
| 65 | RIPK4 | 0.16228754 |
| 66 | ZAP70 | 0.16140640 |
| 67 | PTK6 | 0.15860935 |
| 68 | MAP2K2 | 0.15183389 |
| 69 | BTK | 0.14715537 |
| 70 | ADRBK2 | 0.14389479 |
| 71 | NME1 | 0.14280938 |
| 72 | KDR | 0.13264277 |
| 73 | TYK2 | 0.12694851 |
| 74 | PRKACG | 0.12539153 |
| 75 | NTRK1 | 0.12220303 |
| 76 | KSR2 | 0.11871773 |
| 77 | CAMKK1 | 0.11824941 |
| 78 | PRKCG | 0.11557787 |
| 79 | MARK2 | 0.11551033 |
| 80 | ABL2 | 0.11222335 |
| 81 | MINK1 | 0.11174600 |
| 82 | AKT2 | 0.10812064 |
| 83 | MYLK | 0.10802292 |
| 84 | NLK | 0.10587566 |
| 85 | CSK | 0.10066884 |
| 86 | MAPK11 | 0.10060620 |
| 87 | MAPK12 | 0.09223235 |
| 88 | CAMK4 | 0.08805640 |
| 89 | EPHA4 | 0.08418822 |
| 90 | BLK | 0.08335410 |
| 91 | KSR1 | 0.08203547 |
| 92 | ITK | 0.08199285 |
| 93 | RIPK1 | 0.08134588 |
| 94 | MAP2K6 | 0.07672639 |
| 95 | * PRKACA | 0.07577006 |
| 96 | MAP3K14 | 0.07363228 |
| 97 | ACVR1B | 0.07260161 |
| 98 | PRKCB | 0.07248996 |
| 99 | PDK1 | 0.07091390 |
| 100 | MAP3K2 | 0.07065165 |
| 101 | * PRKCA | 0.06678969 |
| 102 | GRK7 | 0.06139158 |
| 103 | INSR | 0.06050501 |
| 104 | JAK1 | 0.05988688 |
| 105 | DYRK1B | 0.05849621 |
| 106 | NEK9 | 0.05772807 |
| 107 | YES1 | 0.05645542 |
| 108 | TXK | 0.05373340 |
| 109 | ADRBK1 | 0.05229277 |
| 110 | TRPM7 | 0.05044939 |
| 111 | SYK | 0.04820409 |
| 112 | CSF1R | 0.04535131 |
| 113 | MAP3K1 | 0.04410088 |
| 114 | PRKCQ | 0.04038631 |
| 115 | HCK | 0.03944001 |
| 116 | FGR | 0.03802321 |
| 117 | NEK6 | 0.03729713 |
| 118 | TAOK1 | 0.03714922 |
| 119 | IRAK1 | 0.03068237 |
| 120 | RET | 0.02974745 |
| 121 | JAK2 | 0.02971680 |
| 122 | TESK1 | 0.02915483 |
| 123 | * PRKCD | 0.02822055 |
| 124 | CDC42BPA | 0.02815042 |
| 125 | ABL1 | 0.02117688 |
| 126 | MET | 0.02094117 |
| 127 | PTK2B | 0.02085741 |
| 128 | MAP3K11 | 0.02039740 |
| 129 | MAP2K3 | 0.01894323 |
| 130 | CSNK1A1L | 0.01706688 |
| 131 | MAP3K13 | 0.01456295 |
| 132 | LCK | 0.01296543 |
| 133 | MAP2K1 | 0.01202170 |
| 134 | FES | 0.01177521 |
| 135 | TGFBR1 | 0.00668613 |
| 136 | FYN | 0.00249877 |
| 137 | PRKD1 | -0.0247698 |
| 138 | PDGFRB | -0.0241862 |
| 139 | STK3 | -0.0210899 |
| 140 | STK24 | -0.0175860 |
| 141 | RAF1 | -0.0175045 |
| 142 | STK11 | -0.0089121 |
| 143 | LYN | -0.0075030 |
| 144 | MAP3K5 | -0.0058291 |
| 145 | RPS6KA3 | -0.0039180 |
| 146 | PRPF4B | -0.0020309 |
| 147 | FGFR3 | -0.0015781 |
| 148 | MATK | -0.0009469 |
| 149 | IRAK3 | -0.0006672 |
| 150 | IGF1R | -0.0005971 |
| 151 | CDK3 | -0.0005483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.93505662 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.43183139 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.24808928 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.22349387 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.17229091 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.11363110 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.94807829 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.74706467 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72530843 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.56915286 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.48523038 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.45485128 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42049205 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.36535812 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.17011421 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.04080607 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99431360 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.97334379 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.90751957 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81915309 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.79568040 |
| 22 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.69232743 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66144951 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65671818 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62888698 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59626772 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.59284328 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.54813757 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52249945 |
| 30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.46571600 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.45025922 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.44614266 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44487062 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41293594 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.36830589 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21603283 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.19243819 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17196646 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.16898258 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16051876 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14703207 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.12419128 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.09444586 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09325771 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08915648 |
| 46 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03624236 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99777636 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99112719 |
| 49 | Melanoma_Homo sapiens_hsa05218 | 0.99081115 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98501855 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96769535 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93699376 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.91857789 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90904866 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89134170 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89131382 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88444600 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88349119 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87255972 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78767454 |
| 61 | Gap junction_Homo sapiens_hsa04540 | 0.77807337 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77746408 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75315551 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74775054 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73333505 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73103733 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70287831 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70185559 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70057690 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69968739 |
| 71 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.68090603 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67855505 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67598909 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66556644 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.66422045 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.61012613 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59277157 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59228534 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56903773 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55769875 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49886269 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46577904 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46321301 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.46160636 |
| 85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44011036 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43360129 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43320162 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43141909 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41883725 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39935107 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39860848 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39324926 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.36361221 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.36073998 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34673340 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34267867 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33296386 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32114841 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30949155 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30753350 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27196869 |
| 102 | Focal adhesion_Homo sapiens_hsa04510 | 0.26001602 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24901756 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.24577194 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23047764 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20039445 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18666599 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18149520 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.18120884 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16237808 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.16203966 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15834186 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15610466 |
| 114 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.15525479 |
| 115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15441454 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15368073 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.15314456 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.14723843 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.14227913 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11304381 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.10816964 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.10785936 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.07815983 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.07151383 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07013908 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06173290 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.05651402 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.05260809 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04669596 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.04137499 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.03530217 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0085403 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | -0.0074849 |

